chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient waited in post vaccine area for 15 mins post vaccine.  After about 10 minutes the patient fainted from where he was seated in his chair onto the floor and another customer described him as "rigid". He came to after less than a minute. Patient was kept for observation for 30 minutes and given water. He stated he has had fainting spells in the past and that he felt fine. His mother came to pick him up.
sick; flu; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick"; INFLUENZA (non-serious), outcome "unknown", described as "flu".  additional Information: reporter called on behalf of his step son who is sick and having a flu right now. They would like to reschedule the appointment of a second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Light-headed, numbness all over shaky, patient monitored at office for about 2 hours, first time for flu vaccine
Rapid heart rate. Resting rate of 120 to 130 beats per minute for at least 2 days. Then 100 to 110 for another 2 days. After 2 weeks still having trouble with normal activities. Heart beat feels different and I get weak whenever moving quickly for example doing laundry or cleaning the house.
Patient became dizzy with palpitations.  Developed flushing, sweating and shaky, take to Emergency room where a patient developed minimal residual erythema
Patient reports having chest tightness a few minutes after having vaccination. She used her albuterol inhaler and then shortly after this she was evaluated. VSS patient denies SOB, chest pain, palpitations no sensation of airway edema. Patient given 50mg oral Benadryl and after 30 minute observation period she states symptoms completely resolved.
Rash, itching in groin area. Pain in Lymph node of the groin also. Hives. Then rash spread to entire pelvic area, joints (hips, behind knees, under arms). Tongue felt numb.  She took bendryl/antihistamines on her own at first then was prescribed Predisone. Seen by her Ob/Gyn first due to the pain being in the groin area. Then seen by Dermatologist and PCP and Infectious Disease.
severe arm bruising -black over one inch long and wide , arm pain . I received the vaccine since March 5th and still have those issues
Patient experienced redness on left lower bicep that turned into rash. No itching or pain.
Pt started with nausea and dizziness and having a flushed feeling. Then developed chest tightness and itchy all over the body and throat is swollen up.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2022 at 12:25 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Feb-2022 at 12:25 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-FEB-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  The patient received vaccine past its 30 day. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  No treatment medications were reported   This case was linked to MOD-2022-542869 (Patient Link).
4/13 - 4/14: sore arm and fatigue  4/15 - 4/19: nausea, severe headache, swelling and rash at injection site.   4/20 - 5/5: muscle soreness (unsure if it has anything to do with vaccine or completely unrelated)
Patient received Tdap vaccine on 6.12.13 at clinic with no issues at that time. Patient awoke 06/18/2013 AM to a 2 inch by 4 inch area of erythema and edema to right deltoid this AM. Area warm to touch and patient reports area is tender. Erythema circled with a marker. Advised patient to make appointment with PCP for possible cellulitis to right upper arm. Advised that area has been circled and to monitor for spread of infection (erythema extending beyond marked area, streaking redness to ear, fever over 100.5). Advised if this symptoms occur in the next 12-24 hours while waiting for PCP appointment that she must report to urgent care for evaluation. Patient verbalized understanding and has PCP number to call as soon as leaving clinic.
This spontaneous report was received by a physician referring to a 2 years old female patient. The patient's concurrent conditions included asthma, allergies and low blood immunoglobulin A (IGA). The patient's concomitant medications included an unspecified inhaler. The patient did not have any known drug reactions/allergies. In October 2015, the patient was vaccinated with PNEUMOVAX 23 injection (dose, route of administration, lot number and expiration date were not reported) for low pneumococcal titers as prophylaxis. Other suspect therapies included influenza virus vaccine (unspecified) (dosage schedule, route, anatomical location, lot number and expiration date were not reported). The patient received concomitantly an unspecified flu vaccine with the administration of PNEUMOVAX 23. Immediately after administration of PNEUMOVAX 23 the patient seemed pale, became lethargic and then vomited. The patient was taken to the emergency room where she subsequently choked on a fruit snack which resulted in her lips turning blue until the fruit snack was able to be dislodged. It was reported the patient received treatment for the above mentioned adverse events. Also an X-Ray and an electrocardiogram were performed (results not available). At the reporting time, the patient had recovered from the above mentioned events. The causality assessment between the suspect vaccines and the above mentioned events was not reported.
Temperature of 103 F for 2 days, severe chills and body aches. Severe pain in right arm at injection sight with significant redness and arm felt hot.
Dry mouth. Soreness & pain in arm of injection, shoulder & neck stiffness & muscle pain, tiredness. From 30 minutes after injection & continuous throughout the day & night.   While these are not severe, because of the lack of time given for proper research, I felt reporting any side effects (even minor ones) were important for your research & statistics.
Information has been received from a health professional concerning a 7 year old female who on 14-SEP-2000 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 657787/0718U). On 30-JUN-2007 the patient experienced local reaction at injection site. No additional information is available.
Seizure; This is a spontaneous report from a contactable consumer (patient). A 17-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 01Sep2021 16:45 (Batch/Lot Number: EWO191) (at the age of 17-year-old) as dose 2, single for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was doctor's office/urgent care. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included pineapple (reported as Relevant past drug history: Name of Drug as Reported: Pineapple), seizure from an unknown date to an unspecified date (seizure disorder as a young child. Medication and seizure free 8 plus years. Current Anxiety/ depression), ongoing anxiety/depression. Concomitant medication included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported (received within 2 weeks of vaccination). The patient previously received the first dose of BNT162B2, administered in the left arm on 11Aug2021 at 13:00 (Batch/Lot Number: EWO183) (at the age of 17-year-old) for COVID-19 immunization. On 02Sep2021 at 01:45 AM, the patient experienced seizure. The event was reported as non-serious. The patient did not receive treatment for the event. Since the vaccination, the patient has not been tested for COVID-19. Device date was reported as 02Sep2021. The outcome of the event was recovering.   Follow-up attempts are completed. No further information is expected.
Threw lot# away.  1/3/21 am got hives on ankles, 3am, Then around hands 7am.  Then Hives around hips.  Then went to the back.  1/4/21 Dizziness when trying to get up. Symptoms lasted 1/5-1/6. Went to urgent care because hives were all over.  Rec'd Medrol from urgent care along with hydroxyzine.  Got relief on 1/9/21.
Patient c/o pain and described a knot sensation on L deltoid area where vaccine was given. Painful to the touch. Induration was formed on site. Ice pack was applied and instructions were given to take OTC Ibuprofen or Tylenol. Advised patient to move arm. She was able to move arm and finger.
Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Medium, Systemic: Nausea-Medium, Additional Details: Immunizing pharmacist checked patient's blood pressure after syncopal episode, and again before sending patient home. He then called later to follow up and was informed of a second episode, after which he accompanied patient and mother to hospital. He remained with them until she was cleared to go home.
Hospitalized 10/6/2021; COVID-19 positive 10/6/2021; fully vaccinated  Discharge Summary  Health professional (Physician) ? ? Hospitalist BRIEF OVERVIEW: Discharge Provider: Health professional Primary Care Provider: None Physician, MD Admission Date: 10/6/2021 Discharge Date: Oct 14, 2021  Active Hospital Problems  Diagnosis Date Noted POA ? COVID-19 10/06/2021 Yes Resolved Hospital Problems No resolved problems to display. There are no active non-hospital problems to display for this patient. Discharge Disposition:  custodial care facility  Active Issues Requiring Follow-up:  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Confusion  Hypoxia  Conjunctivitis, unspecified conjunctivitis type, unspecified laterality Pneumonia due to COVID-19 virus  COVID-19  HOSPITAL COURSE: Patient is a 74 y.o. male with h/o dementia, left arm tremor, AVM, current COVID infection admitted for CVA/neuro symptoms, CoVID 19 PNA and acute hypoxic respiratory failure.. He had a CC of left sided facial drop that resolved by admission time.  He wast treated with decardron, remdisivir and Lovenox. His acute hypoxic respiratory failure resolved quickly MRI brain found severe chronic small vessel ischemic disease but no acute findings. Neurology recommended outpatient follow. He was cleared from isolation restrictions on 10/13 PT/OT recommended SNF 10/14/2021 Pt S+E. Alert, NAD,RA, Stable at discharge RN provided signout/instructiosn to accepting facility
Patient presented with myopericarditis on 8/16 to Medical Center, Emergency Department and was subsequently admitted for hospital admission from 8/16 to 8/17. Patient received 2nd dose of Pfizer COVID19 vaccine on 8/13. On 8/13 at night, the patient complained of subjective fever when going to sleep. On 8/14, in the morning, the patient complained of pain in the arm. On 8/15, in the morning, the patient began complaining of mild chest pain that was worse when laying down. On 8/15 at night and the following morning on 8/16, the patient complained of worsening chest pain that was aching, intermittent, without radiation on a scale of 8/10.  Echo-cardiogram, EKG, and troponins were ordered. CMP, CBC, CRP, BNP, EKG, CXR reportedly unremarkable with troponin 1741 and received ibuprofen with relief of symptoms.  Patient was admitted to Pediatric Floor and continued management. His troponin was 1741 on presentation and rose to 7,312 on 8/16. His echo and EKG were WNL, showing only early repolarization. Per cardiology EKG and Echo overall reassuring. Patient was treated with ibuprofen for symptomatic relief. Troponins downtrended before discharge. Follow up with PCP and Cardiology in one week from discharge.
Symptoms began at 06:00 on 1/19/21 and included fever, chills, weakness, aches, injection site pain. Tylenol taken.  Notified employee health at the facility.
Pulmonary embolism. Chest pain, shortness of breath, rapid heart rate.
pt with positive COVID test x 1 wk; presents to ED with increase in SOB, cough, fever, malaise; treated with corticosteroids, antiviral, bronchodilators; hx of non-Hodgkins lymphoma, treated with immune therapy; O2 supplementation of BiPAP and Vapotherm NRB; suffered left MCA CVA while in hospital; DNI and no PEG tube placement; comfort measures; pt died in the hospital with daughter at her side
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with VARIVAX dose 1m (dose, lot # and expiry date unknown). On 05-MAY-2014, the patient was vaccinated with improperly stored VARIVAX dose 2 (dose unknown), from lot # H018451 with expiry date of 09-OCT-2014,. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review of records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter.
Pt devel high pitched screaming cry for 2 hrs p/DTP given that day;
Palpitations occurred right after second moderna vaccine. His EKG was normal. He also reported right ear tinnitus and left ear hearing exam was abnormal. He will be referred to respective specialists.
The pt experienced 7 to 8 cm redness/swelling at the site of injection.
On 4/26/21 The patient presents to our clinic with concerns for back pain, fever, shortness of breath, fatigue and coughing. We performed a covid19 antigen test which resulted positive. Based on this and his history and examination we recommended he go straight to the hospital for further evaluation and treatment. He was admitted to  medical center where a PCR was performed and confirmed positive. He was discharged on 4/29. Per his wife, they felt he was discharged too soon and he went to another hospital. He passed away 5/10/2021.  This report is being made in regards to the claim by the CDC that "no one that has been infected with covid19 4 weeks after having the janssen vaccine has been hospitalized." This patient was not only hospitalized but passed away.
We have had two impressive but non life threatening reactions to MMR vaccine Lot 1449AA in patients in our clinic. Two children, unrelated. Both with approx 5 cm indurated lesion. No streaking, fever, or signs of infection.
Patient was given booster dose of 0.25mg for dose #2 instead of full 0.5mg dose.  Dose #1 of moderna received on 10/22/21 at full correct dose.  Patient will be contacted to return ASAP for another 0.25mg dose to complete full second dose per CDC recommendations.
Lt deltoid swollen (Humerous cellulitis) t100, arm sore cough, MD tx APAP  & Amoxil; arm sore 3 days-fine p/that;
36 hours after vaccine my face started swelling rapidly. I had extreme swelling and hardening in the areas where I have HA fillers - lips and tear troughs. Both Restylane products. Ended up going to the ER at 2 AM and receiving angioedema/anaphylaxis protocol. IV benedryl, famotidine, and solumedrol. Was put on prednisone and hydroxyzine for at home care for the next 3 days after event. Swelling went down by the next afternoon.
Fever, chills,nausea,vomiting. Started 10/12/21 4:00pm till 5:00pm 10/13/21
24 YO received pediatric dose; 24 YO received pediatric dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 24-year-old patient who received HAV (Havrix pediatric) for prophylaxis.   On an unknown date, the patient received the 1st dose of Havrix pediatric. On an unknown date, an unknown time after receiving Havrix pediatric, the patient experienced accidental underdose (Verbatim: 24 YO received pediatric dose) and inappropriate age at vaccine administration (Verbatim: 24 YO received pediatric dose). The outcome of the accidental underdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt date: 21-Mar-2023 The nurse accidentally gave pediatric or adolescent Havrix 0.5 mL to a 24-year-old adult.  This office had a nurse accidentally give pediatric or adolescent Havrix 0.5 mL to a 24-year-old adult.  The question was should the patient restart the 2 doses series at 1 mL, or could the office complete the series using 1 mL when patient was due for their second dose. The patient had 0.5 mL Havrix to a 24-year-old adult, which led to accidental underdose and inappropriate age at vaccine administration.
This spontaneous report as received from a company representative refers to a 11-year-old female patient. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 04-APR-2018, the patient was vaccinated with a first dose of GARDASIL 9, 0.5 ml, intramuscularly (lot# and expiration date were not provided), for prophylaxis and with a dose of unspecified diphtheria toxoid, pertussis acellular vaccine (exact dose, frequency, route of administration, lot# and expiration date were not provided) for prophylaxis and with a dose of MENACTRA (exact dose, frequency, route of administration, lot# and expiration date were not provided) for prophylaxis. On 05-APR-2018, the patient was acting different than normal, walking differently, and exhibiting different characteristics. It was not specified which characteristics were different. Her mother took a video of the patients and was going to show the doctor during their appointment. No diagnostic test were performed. The outcome of the events was unknown. The causality assessment was not provided. This is one of two reports received from the same reporter concerning siblings. Sender's Comments: US-009507513-1804USA002912.
didn't follow the storage guidelines of 12 hours and used an open vial from a day or days before for her first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (didn't follow the storage guidelines of 12 hours and used an open vial from a day or days before for her first dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (didn't follow the storage guidelines of 12 hours and used an open vial from a day or days before for her first dose). On 17-Mar-2021, EXPIRED PRODUCT ADMINISTERED (didn't follow the storage guidelines of 12 hours and used an open vial from a day or days before for her first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.   This case was linked to MOD-2021-262495 (Patient Link).
Pt reported waking up with upper right arm swollen on 5/11/2017; in early afternoon reported to pharmacy and it started resolving and then increased in swelling.  Resolved with supportive care.
Pt reports that on Saturday 7/16/16 he woke covered in generalized urticarita/hives.  Pt also reports that he has a reaction at the injection sight of redness, hot, and swollen.  Pt had Adacel left arm same day.  Provider wants to know if there is any indication not to give Prevnar 13 along with Adacel.  Provider also wants to know if there are any indications that pts with asthma should not get prevnar 13.  Pt. denies any breathing difficulities or swelling of face or throat.
G47.33 OBSTRUCTIVE SLEEP APNEA 6/10/2022 DIFFICULTY WALKING J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/21/2022 DIFFICULTY WALKING G47.33 OBSTRUCTIVE SLEEP APNEA 6/10/2022 ALZHEIMERS DISEASE J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/21/2022 ALZHEIMERS DISEASE
I had the covid vaccine administered by Hospital at a site giving the shots. I saw my primary care doctor at the address above  after I developed the rash.  I've developed a rash that appears to be shingles. It affects my back arms, face, scalp and palms of my hands.